Pancreatic cancer oral inverse agonist of RORgT receptor targets primary cancer cells and alters inflammatory mediators of the tumor microenvironment Article

Full Text via DOI: 10.1016/j.annonc.2023.04.467 Web of Science: 001037960400412

Cited authors

  • Johnson D, Bearss D, Kelley L

Publication date

  • 2023

Published in

International Standard Serial Number (ISSN)

  • 0923-7534

Number of pages

  • 1

Start page

  • S157

End page

  • S157


  • 34